Approval · Notice of Compliance 15499 · 2014
IPRAVENT: Notice of Compliance 15499
Issued April 14, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15499
- Date
- April 14, 2014
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Topical anticholinergic
- Canadian reference product
- ATROVENT (Boehringer Ingelheim (Canada) Ltd.)
Products in this notice
Medicinal ingredients
- IPRATROPIUM BROMIDE 0.03 PER
- IPRATROPIUM BROMIDE 0.06 PER